Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewsIndia

India's COVID-19 recovery rate has improved to 24.56%: Niti Aayog CEO Amitabh Kant

Death toll due to COVID-19 rose to 1,008 and the number of cases climbed to 31,787 in the country on Wednesday, registering a record jump of 71 deaths in the last 24 hours, according to the health ministry.

April 29, 2020 / 08:37 PM IST
File image

File image

India's COVID-19 recovery rate has improved from 15 percent on April 19 to 24.56 percent as of Wednesday, Niti Aayog CEO Amitabh Kant said. He also stressed on the need to keep working tirelessly on states and districts with high load of cases to further improve the recovery rate.

"Happy to note that with 7700 + recoveries, our COVID-19 recovery rate has improved. It was 15 percent on 19 April, 19.2 percent on 26 April and 24.56 percent today. We must keep working tirelessly on high case load states and districts to further improve our recovery rate," Kant said in a tweet.

Coronavirus India News LIVE Updates

Death toll due to COVID-19 rose to 1,008 and the number of cases climbed to 31,787 in the country on Wednesday, registering a record jump of 71 deaths in the last 24 hours, according to the health ministry.

There has been a spike of 1,813 cases since Tuesday evening.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Active COVID-19 cases stand at 22,982, while 7,796 people have recovered, and one patient has migrated, the ministry said.

"Thus, around 24.52 percent of the patients have recovered so far," a health ministry official said.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Apr 29, 2020 08:30 pm

stay updated

Get Daily News on your Browser
Sections